Position in BNTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$326,793,184
-$17,306,359 QoQ
Shares Held
3,676,791
+1.7% QoQ
Ownership
1.45%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Dodge & Cox holds $6,385,523,643 across 5 Biotechnology names. BNTX ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,458,238 | $3,444,613,008 | |
| 2 | INCY |
Incyte Corp
|
12,252,356 | $1,153,191,746 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
14,561,759 | $822,593,765 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,929,253 | $638,331,940 | |
| 5 | BNTX |
BioNTech SE
This page
|
3,676,791 | $326,793,184 |
All Filings in BNTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $326,793,184 | 3,676,791 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $344,099,543 | 3,614,491 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $359,676,114 | 3,647,091 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $93,420,717 | 877,437 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||